Humanized monoclonal anti-Rubella Virus IgM antibody, positive for Rubella Virus, manufactured in hybridoma cell culture. Perfectly suited as an alternative to human sera/plasma for the manufacturing of calibrators and controls.
The monoclonal antibodies are offered in two different matrices. The original product line is provided as a cell culture supernatant packaged in 1 mL up to 1 L quantities. The new generation of antibodies is available in an IgG depleted and delipidized human serum matrix with 100 µg up to 25 mg packaging sizes. Production lots are usually offered with a concentration between 100 µg/mL and 150 µg/mL.
Test samples can be offered free of charge.